Johnson & Johnson

October 22, 2019October 22, 2019

Stelara Approved in US to Treat Moderate-to-Severe Ulcerative Colitis

News

The U.S. Food and Drug Administration (FDA) has approved Stelara (ustekinumab) for the treatment of adults with ulcerative colitis (UC) that is moderately to severely active, Janssen Pharmaceuticals, Stelara’s developer and ... Read more

September 6, 2019September 6, 2019

Stelara Approved to Treat Moderate to Severe Ulcerative Colitis in Europe

News

The European Commission (EC) has approved Stelara (ustekinumab) to treat moderately to severely active ulcerative colitis (UC) in adults who are either not responding to, or are intolerant of, standard ... Read more

January 12, 2016January 12, 2016

Crohn’s Disease Treatments to Be Focus of Collaborative Research Contract

News

A research group, a biotech company, and a national French institute will band together to try and develop treatments for patients with Crohn’s disease. Enterome Bioscience SA, a company that ... Read more